# IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

> **NCT03639207** · — · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Hepatitis C Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03639207
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-15
- **Primary completion:** 2019-07-03
- **Final completion:** 2019-07-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Subject Research)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03639207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03639207, "IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03639207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*